The neurotrophic factors (NTF), BDNF and GDNF, have been proposed as potential gene therapeutic agents for Parkinson's disease (PD) to both slow degeneration and increase neuronal function of substantia nigra dopamine (SN-DA) neurons. To evaluate the NTF as rational therapeutic agents for PD, it is crucial to understand the functional roles and mechanisms of action of each NTF on SN-DA cells in both normal- and patho-physiological conditions. Previously used model systems for the evaluation of NTF have suffered from both paucity of DA cells in heterogeneous fetal mesencephalic cultures and the inaccessibility of SN-DA neurons for genetic manipulation in either normal or Parkinson's animal models. Therefore, as a crucial first step in the elucidation of the functional and regulatory roles of the exogenous NTF, we have developed both (1) SN-DA neuronal cell lines and (2) transgenic mouse models with an on-off genetic switch to control the levels of NTF production in SN-DA neurons. In the current proposal the newly developed SN-DA cell lines and transgenic mouse models will be utilized to provide a basic biological rationale for the use of NTF in PD and fetal grafts. [The] current proposal tests the hypothesis that the exogenous NTF differentially promotes DA neuronal survival, DA phenotypic differentiation, and protection against MPTP via direct and/or indirect mechanisms depending on the developmental states of SN-DA neurons.
Specific Aim 1 will address the differential mechanism[s] of neurotrophic and neuroprotective actions of BDNF and GDNF in our SN-DA cells, together with mesencephalic astrocyte coculture system. In complementary studies, Specific Aim 2 will examine the in vivo functional effects of controlled over-expression of BDNF and GDNF on SN-DA neurons during development, aging and in an animal model of PD. The proposed studies will provide both new insights into SN-DA neuronal degeneration during normal aging and PD. The proposed studies will provide both new insights into SN-DA neuronal degeneration during normal aging and PD as well as the biological rationale for gene therapy and SN-DA neuron transplantation in Parkinson""""""""s patients.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
5R01AG014093-04
Application #
6169584
Study Section
Neurological Sciences Subcommittee 1 (NLS)
Program Officer
Wise, Bradley C
Project Start
1997-09-30
Project End
2002-08-31
Budget Start
2000-09-01
Budget End
2001-08-31
Support Year
4
Fiscal Year
2000
Total Cost
$287,419
Indirect Cost
Name
Winifred Masterson Burke Med Research Institute
Department
Type
DUNS #
780676131
City
White Plains
State
NY
Country
United States
Zip Code
10605
Yoo, Myung S; Kawamata, Hibiki; Kim, Dae J et al. (2004) Experimental strategy to identify genes susceptible to oxidative stress in nigral dopaminergic neurons. Neurochem Res 29:1223-34
Yoo, Myung S; Chun, Hong S; Son, Jessica J et al. (2003) Oxidative stress regulated genes in nigral dopaminergic neuronal cells: correlation with the known pathology in Parkinson's disease. Brain Res Mol Brain Res 110:76-84
Chun, Hong S; Yoo, Myung S; DeGiorgio, Lorraine A et al. (2002) Marked dopaminergic cell loss subsequent to developmental, intranigral expression of glial cell line-derived neurotrophic factor. Exp Neurol 173:235-44
Chun, H S; Gibson, G E; DeGiorgio, L A et al. (2001) Dopaminergic cell death induced by MPP(+), oxidant and specific neurotoxicants shares the common molecular mechanism. J Neurochem 76:1010-21
Baker, H; Liu, N; Chun, H S et al. (2001) Phenotypic differentiation during migration of dopaminergic progenitor cells to the olfactory bulb. J Neurosci 21:8505-13
Chun, H S; Lee, H; Son, J H (2001) Manganese induces endoplasmic reticulum (ER) stress and activates multiple caspases in nigral dopaminergic neuronal cells, SN4741. Neurosci Lett 316:5-8
Chun, H S; Son, J J; Son, J H (2000) Identification of potential compounds promoting BDNF production in nigral dopaminergic neurons: clinical implication in Parkinson's disease. Neuroreport 11:511-4
Son, J H; Chun, H S; Joh, T H et al. (1999) Neuroprotection and neuronal differentiation studies using substantia nigra dopaminergic cells derived from transgenic mouse embryos. J Neurosci 19:10-20
Jahng, J W; Houpt, T A; Joh, T H et al. (1998) Differential expression of monoamine oxidase A, serotonin transporter, tyrosine hydroxylase and norepinephrine transporter mRNA by anorexia mutation and food deprivation. Brain Res Dev Brain Res 107:241-6
Jahng, J W; Houpt, T A; Kim, S J et al. (1998) Neuropeptide Y mRNA and serotonin innervation in the arcuate nucleus of anorexia mutant mice. Brain Res 790:67-73